September 22, 2011
ACT Gets First European Stem Cell OK
Advanced Cell Technology Inc. of Marlborough said it has received clearance for a U.K. clinical trial involving human embryonic stem cells.
ACT said the U.K. Medicines and Healthcare products Regulatory Agency agreed to a Phase ½ clinical trial for Stargardt's Macular Dystrophy using a therapy derived from the stem cells. Stargardt's disease causes sight loss and can't be treated yet.
The company has already begun clinical trials for the treatment in the U.S.
WBJ Web Partners
Most Recent
Most Recent
0 Comments